Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 323

Similar articles for PubMed (Select 18439112)

1.

Randomized controlled pilot study of quetiapine in the treatment of adolescent conduct disorder.

Connor DF, McLaughlin TJ, Jeffers-Terry M.

J Child Adolesc Psychopharmacol. 2008 Apr;18(2):140-56. doi: 10.1089/cap.2006.0007.

PMID:
18439112
2.

A 26-week open-label study of quetiapine in children with conduct disorder.

Findling RL, Reed MD, O'Riordan MA, Demeter CA, Stansbrey RJ, McNamara NK.

J Child Adolesc Psychopharmacol. 2007 Feb;17(1):1-9.

PMID:
17343549
3.

A double-blind pilot study of risperidone in the treatment of conduct disorder.

Findling RL, McNamara NK, Branicky LA, Schluchter MD, Lemon E, Blumer JL.

J Am Acad Child Adolesc Psychiatry. 2000 Apr;39(4):509-16.

PMID:
10761354
4.

Atypical antipsychotics for disruptive behaviour disorders in children and youths.

Loy JH, Merry SN, Hetrick SE, Stasiak K.

Cochrane Database Syst Rev. 2012 Sep 12;9:CD008559. doi: 10.1002/14651858.CD008559.pub2. Review.

PMID:
22972123
5.

A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.

DelBello MP, Chang K, Welge JA, Adler CM, Rana M, Howe M, Bryan H, Vogel D, Sampang S, Delgado SV, Sorter M, Strakowski SM.

Bipolar Disord. 2009 Aug;11(5):483-93. doi: 10.1111/j.1399-5618.2009.00728.x.

PMID:
19624387
6.

A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder.

Bowden CL, Grunze H, Mullen J, Brecher M, Paulsson B, Jones M, Vågerö M, Svensson K.

J Clin Psychiatry. 2005 Jan;66(1):111-21.

PMID:
15669897
7.

Efficacy and tolerability of quetiapine in the treatment of borderline personality disorder: A pilot study.

Bellino S, Paradiso E, Bogetto F.

J Clin Psychiatry. 2006 Jul;67(7):1042-6.

PMID:
16889446
8.

A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression.

Calabrese JR, Keck PE Jr, Macfadden W, Minkwitz M, Ketter TA, Weisler RH, Cutler AJ, McCoy R, Wilson E, Mullen J.

Am J Psychiatry. 2005 Jul;162(7):1351-60.

PMID:
15994719
9.
10.

Effectiveness, safety, and pharmacokinetics of quetiapine in aggressive children with conduct disorder.

Findling RL, Reed MD, O'Riordan MA, Demeter CA, Stansbrey RJ, McNamara NK.

J Am Acad Child Adolesc Psychiatry. 2006 Jul;45(7):792-800.

PMID:
16832315
11.

Placebo-controlled study of quetiapine monotherapy in ambulatory bipolar spectrum disorder with moderate-to-severe hypomania or mild mania.

McElroy SL, Martens BE, Winstanley EL, Creech R, Malhotra S, Keck PE Jr.

J Affect Disord. 2010 Jul;124(1-2):157-63. doi: 10.1016/j.jad.2009.11.014. Epub 2009 Dec 5.

PMID:
19963274
12.

Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial.

Tariot PN, Schneider L, Katz IR, Mintzer JE, Street J, Copenhaver M, Williams-Hughes C.

Am J Geriatr Psychiatry. 2006 Sep;14(9):767-76. Epub 2006 Aug 11. Erratum in: Am J Geriatr Psychiatry. 2006 Nov;14(11):988.

PMID:
16905684
13.

Extended release quetiapine fumarate monotherapy for major depressive disorder: results of a double-blind, randomized, placebo-controlled study.

Weisler R, Joyce M, McGill L, Lazarus A, Szamosi J, Eriksson H; Moonstone Study Group.

CNS Spectr. 2009 Jun;14(6):299-313.

PMID:
19668121
14.

Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.

McIntyre RS, Konarski JZ, Jones M, Paulsson B.

J Affect Disord. 2007;100 Suppl 1:S5-14. Epub 2007 Mar 27.

PMID:
17391773
15.

Efficacy and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: a randomized, double-blind, placebo-controlled study.

Kahn RS, Schulz SC, Palazov VD, Reyes EB, Brecher M, Svensson O, Andersson HM, Meulien D; Study 132 Investigators.

J Clin Psychiatry. 2007 Jun;68(6):832-42.

PMID:
17592906
16.

Quetiapine monotherapy in the treatment of patients with bipolar I or II depression and a rapid-cycling disease course: a randomized, double-blind, placebo-controlled study.

Vieta E, Calabrese JR, Goikolea JM, Raines S, Macfadden W; BOLDER Study Group.

Bipolar Disord. 2007 Jun;9(4):413-25.

PMID:
17547587
17.

Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study.

Bandelow B, Chouinard G, Bobes J, Ahokas A, Eggens I, Liu S, Eriksson H.

Int J Neuropsychopharmacol. 2010 Apr;13(3):305-20. doi: 10.1017/S1461145709990423. Epub 2009 Aug 20.

PMID:
19691907
18.

Quetiapine monotherapy in the treatment of depressive episodes of bipolar I and II disorder: Improvements in quality of life and quality of sleep.

Endicott J, Paulsson B, Gustafsson U, Schiöler H, Hassan M.

J Affect Disord. 2008 Dec;111(2-3):306-19. doi: 10.1016/j.jad.2008.06.019. Epub 2008 Sep 5.

PMID:
18774180
19.

A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder.

Malone RP, Delaney MA, Luebbert JF, Cater J, Campbell M.

Arch Gen Psychiatry. 2000 Jul;57(7):649-54.

PMID:
10891035
20.

Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: a flexible-dose, open-label pilot trial.

Katzman MA, Vermani M, Jacobs L, Marcus M, Kong B, Lessard S, Galarraga W, Struzik L, Gendron A.

J Anxiety Disord. 2008 Dec;22(8):1480-6. doi: 10.1016/j.janxdis.2008.03.002. Epub 2008 Mar 13.

PMID:
18455360
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk